An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1. – Logos Biosystems | Advanced Imaging Solutions for Research Excellence

Products

< Back

Customer Reviews

< Back

Resources

< Back

Support

< Back

About Us

< Back

An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1.

2022-07-06

2022. Du X, Li Y, Zhang Z, Zhang C, Hu J, Wang X, … & Zhou J. Biosensors and Bioelectronics, 207, 114166.